Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 347 (9012) , 1357-1361
- https://doi.org/10.1016/s0140-6736(96)91009-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Venous Thromboses and Pulmonary Embolisms in Post-mortem Series: Probable Causes by Correlations of Clinical Data and Basic DiseasesPathology - Research and Practice, 1994
- Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.BMJ, 1992
- Incidence of venous thromboembolism verified by necropsy over 30 years.BMJ, 1991
- Autopsy Proven Pulmonary Embolism in Hospital Patients: Are We Detecting Enough Deep Vein Thrombosis?Journal of the Royal Society of Medicine, 1989
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Fatal Pulmonary Embolism in Hospitalized Non‐surgical PatientsActa Medica Scandinavica, 1985
- LOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKEThe Lancet, 1977
- Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking.BMJ, 1977
- A DOUBLE-BLIND TRIAL OF LOW DOSES OF SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AFTER MYOCARDIAL INFARCTION*1The Lancet, 1973
- Prophylactic Anticoagulant Therapy in the Prevention of Calf-Vein Thrombosis after Myocardial InfarctionNew England Journal of Medicine, 1973